Africa: Only Two Percent of Genomic Material Available for Research Comes From Africa, 54gene Wants to Change That

Photo: 54gene
54gene founder and CEO Dr. Abasi Ene-Obong, centre, among the 54gene staff.

New advances in genetic mapping and manipulation hold the promise of reshaping medical treatments in the 21st century, but thanks to a lack of sufficient infrastructure and apparent scientific disregard, an entire continent is at risk of being left out.

Only 2% of genetic material used for pharmaceutical research comes from the African continent, while genetic data on caucasians makes up 90% of the data and samples available. This is despite the fact that Africans and people of African ancestry are more genetically diverse than all of the other populations in the world combined.

See What Everyone is Watching

More From: TechCrunch

Don't Miss

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.